Survival of patients with metastatic leiomyosarcoma: the MD Anderson Clinical Center for targeted therapy experience

Advanced stage leiomyosarcoma (LMS) is incurable with current systemic antitumor therapies. Therefore, there is clinical interest in exploring novel therapeutic regimens to treat LMS. We reviewed the medical records of 75 consecutive patients with histologically confirmed metastatic LMS, who had bee...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhijie, Shi, Naiyi, Naing, Aung, Janku, Filip, Subbiah, Vivek, Araujo, Dejka M., Patel, Shreyaskumar R., Ludwig, Joseph A., Ramondetta, Lois M., Levenback, Charles F., Ramirez, Pedro T., Piha‐Paul, Sarina A., Hong, David, Karp, Daniel D., Tsimberidou, Apostolia M., Meric‐Bernstam, Funda, Fu, Siqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5224847/
https://www.ncbi.nlm.nih.gov/pubmed/27882721
http://dx.doi.org/10.1002/cam4.956

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5224847/
https://www.ncbi.nlm.nih.gov/pubmed/27882721
http://dx.doi.org/10.1002/cam4.956

Ejemplares similares